This study demonstrates the potential of silencing the expression of the mitochondrial gatekeeper VDAC1 by specific siRNA to treat mesothelioma; si-m/hVDAC1-B can identify both human and mouse VDAC1 and is modified in several nucleotides to increase stability and decrease immunogenicity [60]. Here, VDAC1 is linked to mesothelioma.